Last $2.16 USD
Change Today +0.03 / 1.41%
Volume 1.2M
GERN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 09/29/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for geron corp (GERN)

Year over year, Geron Corporation has seen revenues shrink from $2.7M USD to $1.3M USD, though the company was able to grow net income from a loss of $68.9M USD to a smaller loss of $38.4M USD. A reduction in the percentage of sales devoted to cost of goods sold from 929.42% to 711.93% was a key component in the bottom line growth in the face of falling revenues.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Dec 31
2011
Reclassified
Dec 31
2012
Reclassified
Dec 31
2013
4 Year
Trend
Revenues3.62.42.71.3
TOTAL REVENUES3.62.42.71.3
Cost of Goods Sold61.726.425.29.1
GROSS PROFIT-58.1-23.9-22.5-7.9
Selling General & Admin Expenses, Total18.023.820.415.6
R&D Expenses--42.926.214.0
OTHER OPERATING EXPENSES, TOTAL18.066.746.629.6
OPERATING INCOME-76.2-90.7-69.1-37.5
Interest Expense-0.1-0.2-0.2-0.1
Interest and Investment Income0.81.00.60.2
NET INTEREST EXPENSE0.70.80.40.2
Income (Loss) on Equity Investments-2.3-0.5----
Other Non-Operating Income (Expenses)1.40.60.0-0.3
EBT, EXCLUDING UNUSUAL ITEMS-76.4-89.7-68.7-37.6
Merger & Restructuring Charges---5.4-2.7-0.7
Other Unusual Items, Total-35.0-1.72.5--
In Process R&D Expenses-35.0------
Other Unusual Items---1.72.5--
EBT, INCLUDING UNUSUAL ITEMS-111.4-96.9-68.9-38.4
Earnings from Continuing Operations-111.4-96.9-68.9-38.4
NET INCOME-111.4-96.9-68.9-38.4
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-111.4-96.9-68.9-38.4
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-111.4-96.9-68.9-38.4
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GERN:US $2.16 USD +0.03

GERN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Biorestorative Therapies Inc $0.33 USD +0.0102
BioTime Inc $3.28 USD +0.06
IntelliCell BioSciences Inc $0.0010 USD -0.0002
Neuralstem Inc $3.45 USD +0.11
ReNeuron Group PLC 3.50 GBp 0.00
View Industry Companies
 

Industry Analysis

GERN

Industry Average

Valuation GERN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 273.4x
Price/Book 2.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 158.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GERON CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.